New Treatment For Childhood Brain Tumours, Tovorafenib, Shows Promising Results With An Efficiency Rate Of 91%!
Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery
Kyushu University Hospital
New Treatment Effective In Up To 73% Of Multiple Myeloma Patients!
NYU Langone Hospitals
Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma
